Digital Twin is one of many digitalization techniques enabling the pharma industry to revolutionize their processes with data-driven and automatic ones. It helps its users tackle modern-day challenges, facilitating its customers with cost effectiveness, less time to produce, patient-centric, and quality drugs. Digital Twin adds value to the pharma industry to achieve their goals without depending on older and conventional techniques.
The digital Twin model can be applied to all products or processes, enabling users to visualize it by mapping different parameters to improve the design process.
What is the digital twin?
A Digital Twin is the digital representation of a physical entity that could be a process or product having some biological fingerprint or characteristics. The digital representation can take and understand the same parameters that are understandable and applicable to the physical entities.
The main advantage of a digital twin is that it allows its user to check the response of the process or a product in a realistic manner that mimics accurate testing. On the other hand, traditional or paper-based planning relies on personal expertise, historical trends, and design requirements. The result of conventional planning is still being determined and can only be verified once considered in a practical scenario. The system must be redesigned if desired results are not achieved and must be re-tested until desired results are achieved.
Digital twins can be implemented in many industries, including Pharma, to create a virtual representation before going for physical production. This article focuses on digital twins in the pharmaceutical sector.
Digital Twin in the pharmaceutical industry
The digital twin in the pharma industry is the virtualization of the physical process of the pharma industry and the application of physical parameters, design values, and practical scenarios for analyzing their output behavior. It eliminates the need for physical testing by defining acceptable input-output relationships, thus providing valuable benefits such as cost-effectiveness, less time to market, and quality products.
Some approaches by which digital twins are being implemented are discussed in this section.
Process and product improvements
Process and product improvement are the most critical applications of the digital twin in the pharma industry. The pharma industry commonly responds to various feedback types, such as market demand, regulatory guidelines, and complaints. Digital twin allows testing different process parameters to analyze their behavior without physically creating products and processes.
Digital Twin replicates the desired process in a virtualized model, applying real-world parameters. The digital twin takes the data and models the corresponding behavior of the process.
Training
Training is an essential element of the pharma industry and includes safety, regulatory regulations, and production processes. The digital twin aids in training by creating equipment, instruments, processes, or a virtualized product, allowing the participants to test and enhance their skills. Digital twins also enable the safe application of scenarios without losing process, product, instrument, and equipment.
On the contrary, traditional training systems are complete of limitations, such as
● Planning a training event depends on the availability of a specific process, component, or product. Especially in times of high demand, it becomes more complex and is often delayed.
● The number of participants at a given time is limited and requires multiple sessions due to the unavailability of resources or a participant needing to be more relaxed in their routine responsibilities.
Manufacturing operations
Digital twins can replicate manufacturing operations virtually and allow pharmaceutical personnel to verify various product parameters before taking them into physical production. If the product parameters suffer any deviation, it is immediately detected in the virtual model, allowing the personnel to alter product parameters to save the ongoing production proc...
(All Rights Reserved)